Literature DB >> 6372739

Ceruletide: a new drug for the treatment of schizophrenic patients?

M Albus, M Ackenheil, U Münch, D Naber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6372739     DOI： 10.1001/archpsyc.1984.01790160114018

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  3 in total

1.  Effect of ceruletide on tardive dyskinesia: a pilot study of quantitative computer analyses on electromyogram and microvibration.

Authors:  T Nishikawa; M Tanaka; A Tsuda; H Kuwahara; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia.

Authors:  E Peselow; B Angrist; A Sudilovsky; J Corwin; J Siekierski; F Trent; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke.

Authors:  Alba Simats; Laura Ramiro; Raquel Valls; Helena de Ramón; Paula García-Rodríguez; Cyrille Orset; Laura Artigas; Teresa Sardon; Anna Rosell; Joan Montaner
Journal:  Neurotherapeutics       Date:  2022-02-28       Impact factor: 6.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.